CNC stock icon

Centene
CNC

$68.04
0.16%
 

About: Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 24 million medical members as of June 2023, mostly in Medicaid (67% of membership), the individual exchanges (14%), and Medicare Advantage (6%) plans. The company also serves traditional Medicare users with its Medicare Part D pharmaceutical program.

Employees: 67,700

0
Funds holding %
of 6,702 funds
0
Analysts bullish %
of 15 analysts
0
News positive %
of 17 articles

Fund manager confidence

Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)

36% more call options, than puts

Call options by funds: $196M | Put options by funds: $144M

31% more first-time investments, than exits

New positions opened: 110 | Existing positions closed: 84

30% more repeat investments, than reductions

Existing positions increased: 373 | Existing positions reduced: 288

6% more capital invested

Capital invested by funds: $37.2B [Q4 2023] → $39.3B (+$2.08B) [Q1 2024]

3% more funds holding

Funds holding: 876 [Q4 2023] → 902 (+26) [Q1 2024]

0.14% less ownership

Funds ownership: 93.8% [Q4 2023] → 93.65% (-0.14%) [Q1 2024]

40% less funds holding in top 10

Funds holding in top 10: 15 [Q4 2023] → 9 (-6) [Q1 2024]

Research analyst outlook

15 Wall Street Analysts provided 1 year price forecasts over the past 6 months

Low target
$82
21%
upside
Avg. target
$93
36%
upside
High target
$110
62%
upside

15 analyst ratings

10 positive
67%
neutral
33%
negative
0%
Oppenheimer
Michael Wiederhorn
62%upside
$110
Outperform
Reiterated
21 Jun 2024
Cantor Fitzgerald
Sarah James
32%upside
$90
Overweight
Reiterated
12 Jun 2024
Stephens & Co.
Scott Fidel
22%upside
$83
Equal-Weight
Reiterated
30 May 2024
Baird
Michael Ha
22%upside
$83
Neutral
Initiated
30 May 2024
Barclays
Andrew Mok
53%upside
$104
Overweight
Maintained
2 May 2024

Financial journalist opinion

Based on 17 articles about CNC published over the past 30 days